Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Associate Professor

Director, Anal Dysplasia Clinic and Research Program

Division of Infectious Diseases

University of Pittsburgh

 

Topics of Professional Interest:
  • Human papillomavirus
  • HIV/STD coinfection
  • Anal dysplasia
  • HPV vaccine
Current Professional Summary:

Dr Cranston is an Associate Professor at the University of Pittsburgh. His research interests focus on HPV associated anal dysplasia and biomedical methods of HIV prevention.

Committees and Organizations:
  • International AIDS Society
  • British HIV Association
  • British Association of Sexual Health and HIV
  • Royal College of Physicians
  • American STD Association
Education:
  • University of Edinburgh Medical School (1990)
  • Eastern General Hospital, Edinburgh, Internal Medicine (1993-1996)
  • Guys and St Thomas' Hospital, London, HIV/STD Fellowship (1996-2002)
  • University of California San Francisco, HPV/HIV (1998-2001)
Selected Publications:
  1. Anton PA, Cranston RD, Kashuba A, Hendrix C, Bumpus NN, Richardson-Harman N, Elliott J, Janocko L, Khanukhova E, Dennis RA, Cumberland WG, Ju C, Carballo-Diéguez A, Mauck C, McGowan IM. RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Compared to Oral Tenofovir Disoproxil Fumerate. AIDS Res Hum Retroviruses. 2012 Sep 3.
  2. Cosentino LA, Campbell T, Jett A, Macio I, Zamborsky T, Cranston RD, Hiller SL. Use of Nucleic Acid Amplification Testing for the Diagnosis of Anorectal Sexually Transmitted Infections. Journal of Clinical Microbiology. J Clin Microbiol. 2012 Jun;50(6):2005-8. Epub 2012 Apr 4
  3. Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, Voskanian A, Robbie E, Anton P, Cranston RD. The Slippery Slope: Lubricant Use and Rectal Sexually Transmitted Infections a Newly Identified Risk. STD 2012;39 59-64
  4. Cranston RD, Murphy R, Weiss RE, Da Costa M, Palefsky J, Shoptaw S, Gorbach PM. Anal Human Papillomavirus Infection in a Street Based Sample of Drug using HIV-Positive Men. Int J STD AIDS 2012 Mar;23(3):195-200
  1. Beacher DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, Wiley DJ, Minkoff H, Reddy S, Stammer EE, Gillison ML, D'Souza G.Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiology, Biomarkers & Prevention 2011 Nov 1
  2. Moore MD, Cookson J, CoventryV, Sproat B, Rabe L, Cranston RD, McGowan I,JamesW. Protection of HIV-Neutralizing Aptamers Against Rectal and Vaginal Nucleases: Implications for RNA-Based Therapeutics. J Biol Chem. 2011 January 28; 286(4): 2526–2535
  3. Ho KS and Cranston RD. Anal Cytology Screening in HIV-Positive Men Who Have Sex with Men: What’s New and What’s Now? Current Opin Infect Dis. 2009 Nov 21.
  4. Javanbakht M, Gorbach PM, Amana B, McClain T, Walker S, Cranston RD, Datta SD, Kerndt PR. Concurrency , Sex Partner Risk, and High-Risk Human Papillomavirus Infection Among African American, Asian and Hispanic Women. Sexually Transmitted Disease 2009 Oct 9
  5. Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D, Judson F, Koblin B, Mayer KH, Palefsky JM. Anal human papillomavirus is associated with HIV acquisition in men who have sex with men: the EXPLORE study. AIDS. 2009 Jun 1;23(9):1135-42